Martha Demski

Track

Insider profile

Currently holds positions in Adamas Pharmaceuticals Inc and Chimerix Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Adamas Pharmaceuticals Inc March 1, 2014 -
Independent Chairman of the Board Chimerix Inc June 20, 2018 -
Independent Director Chimerix Inc Jan. 1, 2005 - June 1, 2018
Independent Director Evofem Biosciences Inc July 1, 2014 - Jan. 17, 2018
Martha Demski's trades of Alpha Teknova Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
284.03
Quantity 92,916 -16.2%
Value US$3,550,510
US Chimerix Inc (CMRX)
Transaction date
Purchase
Price
245.80
Quantity 37,799 +29.2%
Value US$1,248,957
US Chimerix Inc (CMRX)
Transaction date
Purchase
Price
273.13
Quantity 51,460 +18.9%
Value US$3,172,768
Transaction date
Purchase
Price
2.29
Quantity 2,200 +110.0%
Value US$5,038
Transaction date
Purchase
Price
2.88
Quantity 2,000 +inf%
Value US$5,760
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
3.25
Quantity 1,584 -100.0%
Value US$5,148
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
3.25
Quantity 2,500 -100.0%
Value US$8,125
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
3.29
Quantity 2,500 -100.0%
Value US$8,224
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
3.27
Quantity 2,500 -100.0%
Value US$8,187
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
3.25
Quantity 5,000 -100.0%
Value US$16,250
US Chimerix Inc (CMRX)
Transaction date
Purchase
Price
3.60
Quantity 18,000 +94.7%
Value US$64,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-01 2025-06-27
PlS Planned sale
92,916 -16.2%
284.03
US$3,550,510 		92,916 -16.2% 284.03 US$3,550,510
2023-05-11 2023-05-10
US Chimerix Inc (CMRX)
B Purchase
37,799 +29.2%
245.80
US$1,248,957 		37,799 +29.2% 245.80 US$1,248,957
2022-05-17 2022-05-17
US Chimerix Inc (CMRX)
B Purchase
51,460 +18.9%
273.13
US$3,172,768 		51,460 +18.9% 273.13 US$3,172,768
2021-06-08 2021-06-07
PlS Planned sale
2,000 -20.0%
5.17
US$10,340 		2,000 -20.0% 5.17 US$10,340
2020-09-14 2020-09-11
B Purchase
2,200 +110.0%
2.29
US$5,038 		2,200 +110.0% 2.29 US$5,038
2020-08-14 2020-08-13
B Purchase
2,000 +inf%
2.88
US$5,760 		2,000 +inf% 2.88 US$5,760
2020-08-11 2020-08-10
US Chimerix Inc (CMRX)
PlS Planned sale
1,584 -100.0%
3.25
US$5,148 		1,584 -100.0% 3.25 US$5,148
2020-08-10 2020-08-07
US Chimerix Inc (CMRX)
PlS Planned sale
2,500 -100.0%
3.25
US$8,125 		2,500 -100.0% 3.25 US$8,125
2020-08-10 2020-08-06
US Chimerix Inc (CMRX)
PlS Planned sale
2,500 -100.0%
3.29
US$8,224 		2,500 -100.0% 3.29 US$8,224
2020-08-06 2020-08-05
US Chimerix Inc (CMRX)
PlS Planned sale
2,500 -100.0%
3.27
US$8,187 		2,500 -100.0% 3.27 US$8,187
2020-08-06 2020-08-04
US Chimerix Inc (CMRX)
PlS Planned sale
5,000 -100.0%
3.25
US$16,250 		5,000 -100.0% 3.25 US$16,250
2019-05-29 2019-05-28
US Chimerix Inc (CMRX)
B Purchase
18,000 +94.7%
3.60
US$64,800 		18,000 +94.7% 3.60 US$64,800